Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    artificial Pancreas Outpatient
Show Display Options
Rank Status Study
1 Completed
Has Results
Artificial Pancreas Control System in an Outpatient Setting
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Artificial Pancreas Control Software
2 Not yet recruiting MMPPC Outpatient Clinical Protocol 2016
Condition: Type 1 Diabetes
Intervention: Device: MMPPC algorithm artificial pancreas
3 Completed
Has Results
Outpatient Control-to-Range: System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Outpatient Control-to-Range
4 Completed Outpatient Control-to-Range: System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: DiAs Diabetes Assistant Wearable Artificial Pancreas Platform
5 Completed Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
Condition: Type 1 Diabetes
Interventions: Device: MD-Logic Artificial Pancreas (MDLAP) system;   Procedure: sensor augmented pump therapy
6 Completed Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing
Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with CTR algorithms
7 Recruiting MMPPC: A Probabilistic Closed-loop Artificial Pancreas to Handle Unannounced Meals and Exercise
Condition: Type 1 Diabetes
Interventions: Device: Inpatient use of the MMPPC/DiAs system;   Device: Outpatient use of the MMPPC/DiAs system
8 Completed Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova
Condition: Type 1 Diabetes Mellitus
Intervention: Device: Portable artificial pancreas system with Control-To-Range
9 Completed Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier
Condition: Type 1 Diabetes Mellitus
Intervention: Device: portable artificial pancreas system with Control-To-Range algorithms
10 Not yet recruiting Fault Detection, Zone MPC and DiAs System in T1D
Condition: Type 1 Diabetes
Intervention: Device: Artificial pancreas system (Algorithm + CGM + pump)
11 Completed Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Condition: Diabetes Mellitus, Type 1
Interventions: Device: CGM and Insulin Pump;   Device: Closed-Loop Control System
12 Not yet recruiting Zone-Model Predictive Control on the Diabetes Assistant (DiAs) Platform Efficacy
Condition: Diabetes Mellitus, Type 1
Intervention: Device: Artificial Pancreas using the Zone-Model Predictive Control
13 Not yet recruiting Zone-Model Predictive Control on the Diabetes Assistant (DiAs) Platform Safety and Feasibility
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Artificial Pancreas using the Zone-Model Predictive Control;   Device: Dexcom G4P sensor
14 Completed
Has Results
Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home Use
Condition: Type 1 Diabetes
Intervention: Device: Closed-Loop Control System
15 Not yet recruiting An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Fixed set point;   Device: Variable set point
16 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 5-day intervention with single-hormone closed-loop strategy;   Other: 5-day intervention with sensor-augmented pump therapy;   Other: 5-day intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
17 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 2 Weeks in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 2-week intervention with sensor-augmented pump therapy;   Other: 2-week intervention with single-hormone closed-loop strategy;   Other: 2-week intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
18 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 2 Weeks in Adolescents and Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 15-week intervention with sensor-augmented pump;   Other: 15-week intervention with single-hormone closed-loop;   Other: 15-week intervention with dual-hormone closed-loop;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
19 Recruiting Four Way Crossover Closed Loop With Exercise Detection
Condition: Type 1 Diabetes
Interventions: Device: Artificial Pancreas Controller in Dual Hormone Mode;   Device: Subject's insulin pump;   Device: Artificial Pancreas Controller in Single Hormone Mode;   Device: Artificial Pancreas Controller in Predictive Low Glucose Suspend Mode
20 Completed
Has Results
Artificial Pancreas Control System in an Inpatient Setting
Condition: Type I Diabetes Mellitus
Intervention: Device: Artificial Pancreas Control Software

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.